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Abstract Deafness is an etiologically heterogeneous trait with many known genetic, environmental causes or
a combination thereof. The identification of more than 120 independent genes for deafness has provided profound
new insights into the pathophysiology of hearing. However, recent findings indicate that a large proportion of both
syndromic and nonsyndromic forms of deafness in Chinese population are caused by a small number of mutations.
This review is focused on syndromic and nonsyndromic deafness as well as on the latest information linking inher-
ited mitochondrial pathologies to a variety of etiologies of sensorineural deafness in Chinese population. Better un-
derstanding of the genetic causes of deafness in Chinese population is important for accurate genetics counseling
and early diagnosis for timely intervention and treatment options.
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Introduction
Hearing loss (HL) is a common congenital disor-
der and one of the most distressing disorders affecting
humanity. Deafness can result from a mutation in a sin-
gle gene or from a combination of mutations in differ-
ent genes; environmental causes, such as medical prob-
lems, environment exposure, trauma, and medications,
or interactions between genetic and environmental fac-
tors. Worldwide, congenital deafness occurs in 1 in
1000 live births, and more than half of these cases are
hereditary(Morton, 1991). Of the estimated minimum
of 50% of cases with inherited hearing loss, 70% are
non-syndromic and 80% of these are autosomal reces-
sive. Non-syndromic hearing loss (NSHL) is most of-
ten sensorineural. It can be divided into DFNA (autoso-
mal dominant deafness, 15 to 20% ), DFNB (autoso-
mal recessive deafness, 80% ), DFN (X-linked deaf-
ness, 1%), and mitochondrial deafness at least 1%. To
date, 114 deafness loci have been reported, 54 DFNA
loci and 60 DFNB loci. More than 40 genes for mono-
genetic NSHL and even more for syndromic HL have
been cloned (http://webhost.ua.ac.be/hhh/). According
to the China Disabled Persons' Federation website, Chi-
na has approximately 21 million people with hearing
loss out of 60 million disabled. Although there has
been a significant advance in the knowledge of the mo-
lecular basis of hereditary deafness in recent years,
there have been few studies in China to evaluate the ef-
fects of genetic etiologic factors. The magnitude of the
problem in China remains largely undefined. We re-
view here the prevalence of GJB2 mutations and other
deafness genes in Chinese population, extrapolating
the worldwide incidence to our 1 billion populations.
Prevalence of deafness in our country is likely to be of
significant public health concern.
Nonsyndromic deafness
GJB2
Connexin 26 has been found to be the most com-
mon cause of deafness the world around. GJB2 en-
codes a gap junction protein expressed in the cochlea
and is thought to be important for recycling potassium
ions that flow into sensory hair cells as part of the trans-
duction current. Mutations of GJB2, which is responsi-
ble for DFNB1 and DFNA3, are the most frequent
cause of inherited hearing loss(Cohn et al, 1999; Fuse
et al, 1999; Kelley et al, 1998). More than 100 different
mutations in GJB2 have been identified in patients with
non-syndromic deafness and a significant difference in
the frequency and distribution of the mutations has
been observed in different populations (http://www.iro.
es/cx26deaf.html). They are responsible for approxi-
mately half the cases in the United States, Europe, Aus-
tralia, and Israel, and have been reported in other popu-
lations as well. Most interestingly, a single mutation,
35delG, accounts for up to 70% of Northern and South-
ern European, as well as American Caucasian popula-
tions, with a carrier frequency ranging from 1.3% to
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2.8%(Gasparini et al, 2000; Green et al, 1999). Anoth-
er GJB2 mutation, the 167delT, accounts for 40% of
the pathologic alleles in the Jewish deaf population
(Sobe et al, 2000) and has a 4% carrier frequency
among Ashkenazi Jews(Morell et al, 1998). The 235
delC mutation is the most prevalent in Eastern Asian
(Japanese, Chinese and Korean) populations, R143W
in Ghana and W24X in Indian and Romany (gypsies)
populations (www.gendeaf.org).
We have conducted mutation screening of GJB2 in
118 deaf Chinese probands, including 60 from simplex
and 58 from multiplex families with non-syndromic
deafness, and 150 normal hearing Chinese controls.
Four mutations, including 235delC, 299-300delAT,
V37I, and 35delG, were found in the patients. Twen-
ty-seven probands (22.9% ) were found to carry only
single GJB2 mutations. Mutations in the exon 1 of
GJB2 were not found nor was the 342-kb deletion of
GJB6. The deletion of cytosine at position 235
(235delC) mutation was the most prevalent mutation
(20.3% of alleles), accounting for 81% of the patholog-
ic alleles in multiplex cases and 67% in simplex cases
(Liu et al, 2002). The finding that 235 delC was the
most common pathologic mutation in inherited deaf-
ness attributed to GJB2 in the Chinese population was
further confirmed by Liu et al (2002). The mutant al-
lele was found in 40 of 43 affected subjects with
GJB2-detectable mutations. These results indicate that
mutations in GJB2 are a major cause of inherited and
sporadic congenital deafness in the Chinese population.
The 235delC mutation, rather than 35delG, is the most
common mutation found in the Chinese deaf popula-
tion.
The high frequency of the 35delG GJB2 allelic
variant in the white population has been shown to be
the result of a founder effect, rather than a mutational
hot spot (Van Laer et al, 2001). The 167delT mutation
present in Ashkenazi Jews has also been attributed to a
founder effect (Morell et al, 1998). Both the 35delG
and 167delT mutations are absent or exceptionally low
in Asian populations, in whom, the 235delC, is the
most prevalent. This mutation accounts for up to 80%
of pathogenic GJB2 alleles among Japanese (Fuse et al,
1999; Abe et al, 2000; Kudo et al, 2000), Koreans
(Park et al, 2000), and Chinese (Liu et al, 2002), with
carrier rates ranging from 1.0% to 1.3%. Interestingly,
the 235delC has not been detected in south Asian
populations from India, Pakistan, Bangladesh, and Sri
Lanka, in whom the prevalent GJB2 mutations are
W24X and W77X (Kelsell et al, 1997; Scott et al,
1998). The 235delC mutation prevalence in Japanese
population has been attributed to a founder effect
(Ohtsuka et al, 2003). We have showed that the high
frequency of the 235delC mutation in East Asian
populations is the result of a founder effect, rather than
a mutation hot spot, and that 235delC among all East
Asian populations is derived from a common ancestral
founder (Yan et al, 2003).
GJB6
A role for GJB6, the gene adjacent to GJB2 on
chromosome 13, was first suggested in 1999. The most
common mutation in GJB6, is a 342-kb deletion, which
causes NSHL when homozygous, or when present on
the opposite allele of a GJB2 mutation. The GJB6 muta-
tion occurs in up to 20% of the hearing-impaired U.S.
population (del Castillo et al, 2003). The GJB6 deletion
may account for 10% of all DFNB1 alleles with an ex-
tremely wide range based on ethnic origin. GJB2 and
GJB6 genes are expressed in the cochlea where they
can combine to form multi-unit hemichannels in the
cell membrane, and function as an integral component
of the potassium regulation in the inner ear.
The 342-kb deletion (GJB6-D13S1830) mutation
is most frequent in Spain, France, the United Kingdom,
Israel, and Brazil (5.9-9.7% of all DFNB1 alleles). It is
less frequent in the USA, Belgium, and Australia
(1.3-4.5% of all DFNB1 alleles), and very rare in
Southern Italy (del Castillo et al, 2003), but has been
found present in Northern Italy at frequencies similar
to those of other European countries (Gualandi 2004).
The deletion has also been found in another study in
Germany (Bolz 2004), but not in Austria (Gunther et
al, 2003), Turkey (Tekin et al, 2003; Uyguner et al,
2003), nor in China (Liu et al, 2002).
GJB3
The Connexin 31 gene (GJB3) mapped to chromo-
some 1p33-p35, encodes for a protein that is 270 amino
acids long. Cx31 has been reported to be responsible for
both DFNA and DFNB. The GJB3 gene was identified by
Xia et al(1998) by mutation analysis in two Chinese fami-
lies with autosomal dominant nonsyndromic sensorineu-
ral deafness. A missense mutation (E183K) and a non-
sense mutation (R180X) ofGJB3were found to be associ-
ated with high-frequency hearing loss.
Following the demonstration that mutations in the
GJB3 gene can cause DFNA, we screened 25 Chinese
families with DFNB to determine whether mutations at
this locus can also cause DFNB. Among the 25 fami-
lies, 2 contained individuals who were compound het-
erozygotes for GJB3 mutations. Sequence analysis in
both families demonstrated an in-frame 3-bp deletion
(423-425delATT); in one allele, which led to the loss
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of an isoleucine residue at codon 141; and a 423A-G
transiton in the other allele, which created an isoleu-
cine 141- to -val missense mutation. Both the deletion
of isoleucine-141 and its substitution by valine could
alter the structure of the third conserved alpha-helical
transmembrane domain (M3) and impair the function
of the gap junction. The data demonstrated that Cx31,
like Cx26, could be responsible for both recessive and
dominant forms of non-syndromic deafness (Liu et al,
2000).
DFNB2 (MYO7A)
Mutations in several unconventional myosins,
have been found to cause hearing loss in both humans
and mice. The Myosin VIIa (MYO7A) protein is an un-
conventional myosin motor composed of a structurally
conserved head, neck, and tail region that binds actin
and hydrolyzes adenosine triphosphate to produce
force and movement. Unconventional myosins partici-
pate in various functions that include endocytosis, regu-
lation of ion channels, localization of calmodulin,
movement of vesicles and particles in the cytoplasm
and anchoring inner ear cell stereocilia.
Mutations in MYO7A, located at 11q13.5, are asso-
ciated with Usher syndrome type 1B. They are also re-
sponsible for both autosomal dominant and recessive
nonsyndromic deafness. We previously identified an
in-frame 9-bp deletion in exon 22 of the MYO7A gene
in affected members of the DFNA11 family (Liu et al,
1997a). We also reported mutations in the MYO7A
gene in 2 of 8 families with autosomal recessive non-
syndromic deafness from the Sichuan province of Chi-
na. In 1 family, 3 affected sibs were homozygous for
an arg244-to-pro mutation. Furthermore, in a Chinese
family with nonsyndromic autosomal recessive deaf-
ness, we found that 2 sibs were compound heterozy-
gotes for an acceptor splice site mutation of intron 3
(IVS3AS, A-G, -2) in one allele, while the other allele
carried a T insertion in exon 28, val1199insT(FS), lead-
ing to a frame shift and stop codon 28 amino acids
downstream (Liu et al, 1997b).
Syndromic deafness
Usher syndrome type IC (USH1C)
Usher syndrome is an inherited disorder that is
characterized by moderate to profound hearing impair-
ment, which is present at birth or shortly thereafter, and
progressive vision loss due to retinitis pigmentosa
(RP), a degeneration of the retina. It is the major cause
of deaf blindness. About 10,000 to 15,000 people in
the United States have Usher syndrome. It is estimated
to account for approximately 50% of all individuals
who are both deaf and blind (Boughman et al, 1983),
18% of those with RP and 3-6% of the congenitally
deaf population (Vernon, 1969). The frequency of Ush-
er syndrome was estimated to be 3.0/100,000 in Scandi-
navia (Hallgren, 1959) and 4.4/100,000 in the United
States (Boughman et al, 1983). Usher syndrome is both
clinically and genetically heterogeneous. Three clinical
subtypes have been defined based on the onset of deaf-
ness and RP, and the presence or absence of vestibular
dysfunction (Keats and Corey, 1999).
Usher syndrome type I is an autosomal recessive
disorder characterized by profound congenital deaf-
ness, vestibular areflexia, and progressive RP. It is the
most common cause of combined deafness and blind-
ness in developed countries. At least 11 loci have been
mapped for Usher syndrome, eight of which have been
cloned (Ahmed et al, 2003). Mutations in five different
genes can cause USH1: MYO7A(USH1B) encodes the
actin-based motor protein myosin VIIa (Weil et al,
1995). USH1C encodes a PDZ (postsynaptic density,
disc large, zonula occludens) domain-containing pro-
tein named harmonin (Verpy et al, 2000; Bitner-Glin-
dzicz et al, 2000). Defects in the genes encoding two
cadherin-related proteins, cadherin 23 and protocad-
herin 15, have been shown to cause USH1D (Bolz et
al, 2001; Bork et al, 2001) and USH1F (Ahmed et al,
2001; Alagramam et al, 2001), respectively. The fifth
USH1 gene, USH1G, codes for a scaffold protein that
contains three ankyrin-like domains and a SAM (sterile
alpha motif) domain motif, and its C-terminal tripep-
tide presents a class I PDZ-binding motif (Weil et al,
2003).
The USH1C gene contains 28 coding exons span-
ning 51 kb, and three subclasses of harmonin isoforms
are found as a result of alternative splicing of eight ex-
ons. The USH1C locus was mapped to chromosome
11p in Louisiana Acadian families (Keats et al, 1994;
Verpy et al, 2000; Bitner-Glindzicz et al, 2000). The
major isoform of harmonin contains 552 amino acids
and 3 PDZ domains. Verpy et al (2000) proposed that
mutation in the USH1C gene also underlies the form of
nonsyndromic autosomal recessive neurosensory deaf-
ness designated DFNB18, which maps to the same re-
gion of 11p. We have indeed found in 1 of 32 Chinese
multiplex families with nonsyndromic recessive deaf-
ness without RP, a C to G transversion in the alterna-
tively spliced exon D, predicting an arginine to proline
substitution at codon 608 (R608P) in the proline-, ser-
ine- and threonine-rich region of harmonin. These find-
ings show that USH1C mutations can also cause
non-syndromic deafness (Ouyang et al, 2000).
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Usher syndrome type II (USH2)
Type II (USH2) is the most frequent and account-
ing for about 70% of all Usher syndrome. The patients
tend to have less severe hearing impairment and have
normal vestibular response. Currently, three loci have
been identified for USH2. Of these, two genes have
been cloned (Eudy et al, 1998; Weston et al, 2004).
The USH2A gene is on chromosome 1q and encodes a
171 kDa protein, usherin with 1,551 amino acids
(Eudy et al, 1998). The USH2A transcript is expressed
primarily in the cochlea and the cells of the outer nucle-
ar layer of the retina. At least 30 different mutations
are found in USH2A, which consists of 21 exons (the
first of which is noncoding), spanning at least 105 kb.
The most frequent mutation, 2299delG, was found to
be present in more than 20% of USH2A patients in Eu-
rope and the United States, as well as in some USH3
patients (Liu et al, 1999). In addition, the 2299delG
mutation has been observed in patients whose primary
disorder is RP and who report minimal hearing loss.
Another USH2A mutation, Cys759Phe, was found in
about 4.5% of nonsyndromic autosomal recessive RP
(Rivolta et al, 2000).
We performed a mutation analysis of the USH2A
gene in 23 families with Usher syndrome, 10 of which
had a diagnosis of atypical Usher syndrome, from the
United Kingdom and China. We found that most of the
families with USH2 carried the 2299delG mutation. Of
the 12 families with the 2299delG mutation, eight, in-
cluding one Chinese family, had the typical USH2 phe-
notype (congenital moderate to severe hearing impair-
ment, normal vestibular function, and postpubertal on-
set of RP). However, one Chinese patient among the 4
affected individuals from the remaining 4 families car-
rying the 2299delG mutation showed atypical Usher
syndrome features, with progressive hearing impair-
ment, variable vestibular function, and RP (Liu et al,
1999).
Pendred syndrome
Pendred syndrome is an inherited disorder that ac-
counts for as much as 10% of hereditary deafness (Fra-
ser, 1965). The syndrome is characterized by congeni-
tal severe-to-profound sensorineural hearing loss
(SNHL) and euthyroid goiter. Goiter is not present at
birth and develops in early puberty (40% ) or adult-
hood. Vestibular function is abnormal in the majority
of affected persons. Recessive mutations of the
SLC26A4 (PDS) gene on chromosome 7q can cause
sensorineural deafness with goiter (Everett et al, 1997)
or NSHL without goiter (Li, 1998). Mutations in the
SLC26A4 gene are identified in about 50% of multi-
plex families. These mutations disrupt in vitro trans-
membrane anion/base exchange activity of the
SLC26A4 polypeptide, pendrin. (Scott, 2000).
Currently, more than 90 different mutations in
SLC26A4 have been identified in patients with NSHL
and a significant difference in the frequency and distri-
bution of the mutations has been observed in different
populations(http://www.medicine.uiowa.e d u / p e n-
d r e d a n d b o r / Pendred% 20Syndrome.htm) . Park
et al. (2003) performed a mutation screening of the sev-
en exons of the SLC26A4 gene in East Asian deaf pro-
bands with sporadic or familial severe to profound pre-
lingual deafness, including 86 Chinese affected sub-
jects. They identified 3 mutations (S252P, IVS7-2 A>
G, N392Y) in 5 out of 86 (5.8%) Chinese probands.
Mitochondrial DNA mutations associated with
syndromic andnonsyndromic deafness :
Mitochondrial (mt) pathology plays an important
role in both inherited and acquired hearing loss. SNHL
is present in 42 to 70% of individuals with mt disorders
and can be syndromic and non-syndromic (Jacobs,
1997; Fischel-Ghodsian, 1998, 1999). MtDNA muta-
tions have been identified in >3% of patients with
SNHL (Sinnathuray, 2003). Mutations in mtDNA have
also been found to be associated with both aminoglyco-
side-induced and nonsyndromic deafness (Fisch-
el-Ghodsian 1999; Van Camp and Smith, 2000).
In 1992, several families with diabetes mellitus and
SNHL were described, and surprisingly were found to
have inherited the heteroplasmic A3243G mutation in
the gene for tRNAleu (UUR). The mutation is the com-
mon cause of the MELAS syndrome (mitochondrial en-
cephalomyopathy, lactic acidosis, and stroke-like epi-
sodes) (Reardon et al, 1992; van den Ouweland et al,
1992). The 3243A>G mutation in mtDNA frequently
leads to SNHL (Gold and Rapin, 1994; Sue et al,
1998). The frequency of the A3243G mutation among
the diabetic population is about 1%. The mutation has
also been found in diabetic Japanese (Iwanishi et al.,
1995) and Korean (Lee et al, 1997) patients. Xiang et
al. (1995) and Chuang et al(1995) showed that the mu-
tation was associated with type II diabetes in the main-
land and Taiwan Chinese respectively.
The mitochondrial tRNASer(UCN) (MTTS1) appears
to be a hot spot for mtDNA mutations associated with
NSHL. Four deafness-associated mutations, A7445G
(Fischel-Ghodsian, 1995; Reid, 1994; Sevior，1998),
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Hearing
impairment
Nonsyndromic
Syndromic
Gene and protein
GJB2 Connexin 26
MYO7A myosin
VIIA
GJB3
12S rRNA
USH1C harmonin
USH2A usherin
SLC26A4 Pendrin
tRNALeu(UUR)
Chr.Location(Locus)
13q11-12 (DFNB1)
11q13.5(USH1B)
13q12(DFBA2)
MT
11p15.1 (DFNB18)
1q41 (USH2A)
7q31(DFNB4)
MT
Mutation
235delC
299-300delAT
V37 I
35delG
R244P
IVS3-2A＞G
3596_3597ins T
R180X
E183K
423delATT;
I141V
A827G
961C insertion
T1095C
C1494T
1555A＞G
P608R
2299delG
IVS7-2A
N392Y
S448X
G316X
919-2A＞G
3243A>G
Refs
Liu, 2002
Liu, 2002
Liu, 2002
Liu, 2002
Liu, 1997a
Liu, 1997a
Liu, 1997a
Xia, 1998
Xia, 1998
Liu, 2000
Liu, 2000
Li, 2005
Li, 2005
Li, 2005
Zhao, 2005
Wang, 2005
Li, 2005
Hu, 1991
Ouyang, 2002
Liu, 1999
Yong AM, 2001
Hu, 2005
Hu, 2005
Dai, 2005
Dai, 2005
Xiang, 1995
Table1. Mutations underlying syndromic and nonsyndromic hearing loss in Chinese families
7472insC (Jaksch, 1998; Verhoeven, 1999), T7510C
(Hutchin, 2000) and T7511C (Sue, 1999; Ishikawa,
2002; Chapiro, 2002) have been identified in this gene.
The mitochondrial 12S rRNA(MTRNR1) is anoth-
er hot spot for mtDNA mutations.
The homoplasmic A1555G mutation of this rRNA
has been associated with aminoglycoside-induced and
NSHL in many families of different population
(Hutchin et al, 1993; Prezant et al, 1993; Matthijs et al,
1996; Pandya et al, 1987; Estivill et al, 1998; del Castil-
lo et al, 2003; Li et al, 2004a, b; Young et al, 2005).
Mutations at position 961 of MTRNR1 have also
been implicated in aminoglycoside ototoxicity and
non-syndromic deafness (Casano et al, 1999; Li et al,
2004a). Furthermore, the T1095C mutation in the same
rRNA has also been shown to be associated with hear-
ing loss (Li 2005;Wang et al, 2005). Most recently, the
homoplasmic C1494T mutation in the highly con-
served decoding site of this rRNA has been associated
with both aminoglycoside-induced and non-syndromic
hearing loss in a large Chinese family (Li, 2005).
Li et al. (2005) conducted a systematic mutational
screening of the mitochondrial 12S rRNA gene in a
Chinese pediatric population with sporadic aminoglyco-
side-induced and NSHL. They showed that aminogly-
coside ototoxicity is responsible for 48% of cases. Mu-
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tations at position 961 in the MTRNR1gene accounted
for ~1.7% and 4.4% cases of aminoglycoside-induced
and NSHL, respectively in this Chinese clinical popula-
tion. The frequency of the A1555G mutation was ~
13% and ~2.9% in these Chinese pediatric subjects
with aminoglycoside-induced and non-syndromic hear-
ing loss, respectively.
Deafness genes in Chinese families
Deafness genes segregating non-syndromic/syn-
dromic autosomal recessive inheritance, contribute to a
high percentage of genetic cause of deafness in China.
Localization and cloning of deafness genes have been
performed in China since 1990s. Gene mapping and
mutations screening have been carried out in large
multi-generational families. The genes associated with
deafness in Chinese families have been reported in the
following studies: (1) GJB3 was cloned in China and
mapped to human chromosome 1p33-p35. Mutation
analysis revealed that mutations of the gene were asso-
ciated with high-frequency hearing loss(Xia et al.,
1998). (2) Xiao et al (2001) mapped the DFNA39 lo-
cus and showed that distinct mutations in the dentin sia-
lophosphoprotein gene(DSPP) are responsible for the
clinical manifestations of Dentinogenesis imperfecta1
with or without DFNA39. (3) Xia et al (2002) de-
scribed a Chinese pedigree with autosomal dominant
nonsyndromic hearing loss mapped to chromosome
5q31.1-q32. (4) Yu et al (2003) reported a second muta-
tion in the DFNA5 gene, leading to skipping of exon 8
of DFNA5. (5) Wang et al (2004a) performed a genetic
analysis in a Chinese deaf-mute family with X-linked
recessive inheritance. (6) Wang et al (2004b) reported a
Y-linked inheritance of non-syndromic hearing impair-
ment in a large Chinese family. (7) The DFNA41 locus
was mapped on the long arm of chromosome
12q24-qter(Blanton et al, 2002; Yan et al, 2005a). (8)
Yan et al(2005b) reported mapping of the DFNA53 lo-
cus on the long arm of chromosome 14 at 14q11.2-q12,
through studying a large multi-generational Chinese
family with post-lingual, high frequency hearing loss
that progressed to involve all frequencies. (9) SLC26A4
defects(DFNB4) on 7q31 were reported to be the
causes of Pendred syndrome(Dai P et al 2005).
Concluding remarks
The GJB2 gene accounts for approximately
13-26.7% of the molecular causes of deafness in China
(Liu, 2002), indicating that there are several more
genes involved in the causation of deafness that need
to be unfolded. The 235delC mutation in GJB2 has
been shown to be the most prevalent mutation (20.3%
of alleles), accounting for 81% of the pathologic alleles
in multiplex cases and 67% in simplex cases (Liu,
2002). Mutations at 961 position, T1095C and 1555A>
G mutations in 12S rRNA are hot spot mutations in
Chinese population. Mutations that are involved in syn-
dromic and nonsyndromic deafness found in Chinese
population are reported in Table 1. Therefore, testing
for these mutations is the first step toward a molecular
diagnosis of deafness. Thorough investigation of the
etiology of hearing loss is necessary for accurate genet-
ic counseling and for the implementation and assess-
ment of any future gene therapy.
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